Table 1 Demographics
From: uPA is upregulated by high dose celecoxib in women at increased risk of developing breast cancer
| Â | Celecoxib Dose | |
|---|---|---|
| Â | 200 mg twice daily NAF (plasma) | 400 mg twice daily NAF (plasma) |
Samples | 9 (17) | 11 (25) |
Age (years) | Â | Â |
Median | 46 (51) | 51 (50) |
Range | 23–67 (23–68) | 30–68 (30–81) |
Menopause | Â | Â |
Pre | 2 (4) | 5 (11) |
Post | 7 (13) | 6 (14) |